Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2015

Open Access 01-12-2015 | Meeting abstract

The impact of sustained hyperglycemia, metabolic memory and hba1c variability in the development of chronic complications in patients with type 1 diabetes

Authors: Larissa da Rosa Carolina Garcia Franco, Marcus Miranda, Joana Dantas, Debora Baptista Araújo, Marcus Vinicius Pinto, Leticia Maria Alcantara Margallo, João Batista Jornada Ben, Melanie Rodacki, Lenita Zajdenverg

Published in: Diabetology & Metabolic Syndrome | Special Issue 1/2015

Login to get access

Excerpt

Sustained hyperglycaemia has been linked to the development of chronic complications of type 1 diabetes (T1D) in most populations, especially if it occurs in the first few yrs. of the disease. However, this has been poorly studied in the Brazilian multi-ethnic population. …
Metadata
Title
The impact of sustained hyperglycemia, metabolic memory and hba1c variability in the development of chronic complications in patients with type 1 diabetes
Authors
Larissa da Rosa Carolina Garcia Franco
Marcus Miranda
Joana Dantas
Debora Baptista Araújo
Marcus Vinicius Pinto
Leticia Maria Alcantara Margallo
João Batista Jornada Ben
Melanie Rodacki
Lenita Zajdenverg
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue Special Issue 1/2015
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-7-S1-A29

Other articles of this Special Issue 1/2015

Diabetology & Metabolic Syndrome 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine